nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—breast cancer	0.29	1	CbGaD
Vecuronium—ABCB1—Toremifene—breast cancer	0.0883	0.223	CbGbCtD
Vecuronium—ABCB1—Lapatinib—breast cancer	0.0644	0.162	CbGbCtD
Vecuronium—ABCB1—Vinorelbine—breast cancer	0.0357	0.0901	CbGbCtD
Vecuronium—ABCB1—Tamoxifen—breast cancer	0.0322	0.0813	CbGbCtD
Vecuronium—ABCB1—Mitoxantrone—breast cancer	0.0314	0.0793	CbGbCtD
Vecuronium—ABCB1—Gemcitabine—breast cancer	0.0278	0.0701	CbGbCtD
Vecuronium—ABCB1—Paclitaxel—breast cancer	0.0251	0.0633	CbGbCtD
Vecuronium—ABCB1—Irinotecan—breast cancer	0.0248	0.0625	CbGbCtD
Vecuronium—ABCB1—Vinblastine—breast cancer	0.022	0.0555	CbGbCtD
Vecuronium—ABCB1—Docetaxel—breast cancer	0.0181	0.0458	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—breast cancer	0.0135	0.0341	CbGbCtD
Vecuronium—ABCB1—Methotrexate—breast cancer	0.0131	0.033	CbGbCtD
Vecuronium—Pipecuronium—BCHE—breast cancer	0.00224	0.525	CrCbGaD
Vecuronium—Pancuronium—BCHE—breast cancer	0.00203	0.475	CrCbGaD
Vecuronium—Dermatitis—Fulvestrant—breast cancer	0.000676	0.00267	CcSEcCtD
Vecuronium—Bronchospasm—Gemcitabine—breast cancer	0.000674	0.00266	CcSEcCtD
Vecuronium—Connective tissue disorder—Vinorelbine—breast cancer	0.000671	0.00265	CcSEcCtD
Vecuronium—Rash—Toremifene—breast cancer	0.000668	0.00263	CcSEcCtD
Vecuronium—Dermatitis—Toremifene—breast cancer	0.000667	0.00263	CcSEcCtD
Vecuronium—Erythema—Goserelin—breast cancer	0.000663	0.00262	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—breast cancer	0.000659	0.0026	CcSEcCtD
Vecuronium—Urticaria—Letrozole—breast cancer	0.000658	0.0026	CcSEcCtD
Vecuronium—Urticaria—Anastrozole—breast cancer	0.000658	0.0026	CcSEcCtD
Vecuronium—Hypersensitivity—Ixabepilone—breast cancer	0.000648	0.00256	CcSEcCtD
Vecuronium—Connective tissue disorder—Thiotepa—breast cancer	0.00064	0.00253	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—breast cancer	0.00064	0.00252	CcSEcCtD
Vecuronium—Angioedema—Tamoxifen—breast cancer	0.000634	0.0025	CcSEcCtD
Vecuronium—Cardiac disorder—Vinorelbine—breast cancer	0.000633	0.0025	CcSEcCtD
Vecuronium—Flushing—Vinorelbine—breast cancer	0.000633	0.0025	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—breast cancer	0.000631	0.00249	CcSEcCtD
Vecuronium—Urticaria—Idarubicin—breast cancer	0.000624	0.00246	CcSEcCtD
Vecuronium—Angiopathy—Vinorelbine—breast cancer	0.000619	0.00244	CcSEcCtD
Vecuronium—Immune system disorder—Vinorelbine—breast cancer	0.000616	0.00243	CcSEcCtD
Vecuronium—Mediastinal disorder—Vinorelbine—breast cancer	0.000615	0.00243	CcSEcCtD
Vecuronium—Hypersensitivity—Anastrozole—breast cancer	0.00061	0.00241	CcSEcCtD
Vecuronium—Cardiac disorder—Thiotepa—breast cancer	0.000605	0.00239	CcSEcCtD
Vecuronium—Erythema—Vinorelbine—breast cancer	0.000594	0.00234	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—breast cancer	0.000592	0.00234	CcSEcCtD
Vecuronium—Angiopathy—Thiotepa—breast cancer	0.000591	0.00233	CcSEcCtD
Vecuronium—Immune system disorder—Thiotepa—breast cancer	0.000589	0.00232	CcSEcCtD
Vecuronium—Rash—Exemestane—breast cancer	0.000588	0.00232	CcSEcCtD
Vecuronium—Mediastinal disorder—Thiotepa—breast cancer	0.000587	0.00232	CcSEcCtD
Vecuronium—Dermatitis—Exemestane—breast cancer	0.000587	0.00232	CcSEcCtD
Vecuronium—Muscular weakness—Paclitaxel—breast cancer	0.000585	0.00231	CcSEcCtD
Vecuronium—Hypersensitivity—Idarubicin—breast cancer	0.000579	0.00228	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000575	0.00227	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—breast cancer	0.000569	0.00224	CcSEcCtD
Vecuronium—Erythema—Thiotepa—breast cancer	0.000567	0.00224	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000561	0.00221	CcSEcCtD
Vecuronium—Anaphylactic shock—Melphalan—breast cancer	0.000555	0.00219	CcSEcCtD
Vecuronium—Rash—Ixabepilone—breast cancer	0.000554	0.00219	CcSEcCtD
Vecuronium—Dermatitis—Ixabepilone—breast cancer	0.000554	0.00219	CcSEcCtD
Vecuronium—Connective tissue disorder—Irinotecan—breast cancer	0.000553	0.00218	CcSEcCtD
Vecuronium—Angioedema—Vinorelbine—breast cancer	0.000543	0.00214	CcSEcCtD
Vecuronium—Tachycardia—Melphalan—breast cancer	0.000542	0.00214	CcSEcCtD
Vecuronium—Anaphylactic shock—Goserelin—breast cancer	0.000541	0.00214	CcSEcCtD
Vecuronium—Skin disorder—Melphalan—breast cancer	0.000539	0.00213	CcSEcCtD
Vecuronium—Connective tissue disorder—Gemcitabine—breast cancer	0.000539	0.00212	CcSEcCtD
Vecuronium—Shock—Goserelin—breast cancer	0.000533	0.0021	CcSEcCtD
Vecuronium—Nervous system disorder—Goserelin—breast cancer	0.000531	0.00209	CcSEcCtD
Vecuronium—Tachycardia—Goserelin—breast cancer	0.000528	0.00208	CcSEcCtD
Vecuronium—Skin disorder—Goserelin—breast cancer	0.000526	0.00207	CcSEcCtD
Vecuronium—Face oedema—Capecitabine—breast cancer	0.000526	0.00207	CcSEcCtD
Vecuronium—Cardiac disorder—Irinotecan—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Flushing—Irinotecan—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Rash—Letrozole—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Rash—Anastrozole—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Dermatitis—Anastrozole—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Dermatitis—Letrozole—breast cancer	0.000522	0.00206	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—breast cancer	0.000519	0.00205	CcSEcCtD
Vecuronium—Hypotension—Melphalan—breast cancer	0.000518	0.00205	CcSEcCtD
Vecuronium—Angiopathy—Irinotecan—breast cancer	0.000511	0.00201	CcSEcCtD
Vecuronium—Cardiac disorder—Gemcitabine—breast cancer	0.000509	0.00201	CcSEcCtD
Vecuronium—Immune system disorder—Irinotecan—breast cancer	0.000508	0.00201	CcSEcCtD
Vecuronium—Mediastinal disorder—Irinotecan—breast cancer	0.000507	0.002	CcSEcCtD
Vecuronium—Hypotension—Goserelin—breast cancer	0.000506	0.002	CcSEcCtD
Vecuronium—Urticaria—Chlorambucil—breast cancer	0.000506	0.00199	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000502	0.00198	CcSEcCtD
Vecuronium—Angiopathy—Gemcitabine—breast cancer	0.000497	0.00196	CcSEcCtD
Vecuronium—Rash—Raloxifene—breast cancer	0.000496	0.00195	CcSEcCtD
Vecuronium—Rash—Idarubicin—breast cancer	0.000496	0.00195	CcSEcCtD
Vecuronium—Immune system disorder—Gemcitabine—breast cancer	0.000495	0.00195	CcSEcCtD
Vecuronium—Dermatitis—Raloxifene—breast cancer	0.000495	0.00195	CcSEcCtD
Vecuronium—Dermatitis—Idarubicin—breast cancer	0.000495	0.00195	CcSEcCtD
Vecuronium—Mediastinal disorder—Gemcitabine—breast cancer	0.000494	0.00195	CcSEcCtD
Vecuronium—Erythema—Mitoxantrone—breast cancer	0.00049	0.00193	CcSEcCtD
Vecuronium—Anaphylactic shock—Vinorelbine—breast cancer	0.000485	0.00191	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—breast cancer	0.000481	0.0019	CcSEcCtD
Vecuronium—Muscular weakness—Capecitabine—breast cancer	0.00048	0.00189	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.00048	0.00189	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—breast cancer	0.000478	0.00189	CcSEcCtD
Vecuronium—Erythema—Gemcitabine—breast cancer	0.000477	0.00188	CcSEcCtD
Vecuronium—Nervous system disorder—Vinorelbine—breast cancer	0.000475	0.00188	CcSEcCtD
Vecuronium—Tachycardia—Vinorelbine—breast cancer	0.000473	0.00187	CcSEcCtD
Vecuronium—Skin disorder—Vinorelbine—breast cancer	0.000471	0.00186	CcSEcCtD
Vecuronium—Erythema—Fluorouracil—breast cancer	0.000469	0.00185	CcSEcCtD
Vecuronium—Hypersensitivity—Chlorambucil—breast cancer	0.000469	0.00185	CcSEcCtD
Vecuronium—Bronchospasm—Capecitabine—breast cancer	0.000463	0.00183	CcSEcCtD
Vecuronium—Nervous system disorder—Thiotepa—breast cancer	0.000454	0.00179	CcSEcCtD
Vecuronium—Hypotension—Vinorelbine—breast cancer	0.000453	0.00179	CcSEcCtD
Vecuronium—Tachycardia—Thiotepa—breast cancer	0.000452	0.00178	CcSEcCtD
Vecuronium—Connective tissue disorder—Paclitaxel—breast cancer	0.000451	0.00178	CcSEcCtD
Vecuronium—Urticaria—Tamoxifen—breast cancer	0.00045	0.00178	CcSEcCtD
Vecuronium—Skin disorder—Thiotepa—breast cancer	0.00045	0.00177	CcSEcCtD
Vecuronium—Urticaria—Melphalan—breast cancer	0.000441	0.00174	CcSEcCtD
Vecuronium—Urticaria—Goserelin—breast cancer	0.00043	0.0017	CcSEcCtD
Vecuronium—Hypersensitivity—Vinblastine—breast cancer	0.00043	0.0017	CcSEcCtD
Vecuronium—Cardiac disorder—Paclitaxel—breast cancer	0.000426	0.00168	CcSEcCtD
Vecuronium—Flushing—Paclitaxel—breast cancer	0.000426	0.00168	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—breast cancer	0.000419	0.00165	CcSEcCtD
Vecuronium—Hypersensitivity—Tamoxifen—breast cancer	0.000418	0.00165	CcSEcCtD
Vecuronium—Angiopathy—Paclitaxel—breast cancer	0.000416	0.00164	CcSEcCtD
Vecuronium—Immune system disorder—Paclitaxel—breast cancer	0.000415	0.00164	CcSEcCtD
Vecuronium—Mediastinal disorder—Paclitaxel—breast cancer	0.000414	0.00163	CcSEcCtD
Vecuronium—Hypersensitivity—Melphalan—breast cancer	0.000409	0.00161	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000403	0.00159	CcSEcCtD
Vecuronium—Anaphylactic shock—Mitoxantrone—breast cancer	0.0004	0.00158	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—breast cancer	0.0004	0.00158	CcSEcCtD
Vecuronium—Erythema—Paclitaxel—breast cancer	0.0004	0.00158	CcSEcCtD
Vecuronium—Hypersensitivity—Goserelin—breast cancer	0.000399	0.00157	CcSEcCtD
Vecuronium—Shock—Irinotecan—breast cancer	0.000393	0.00155	CcSEcCtD
Vecuronium—Shock—Mitoxantrone—breast cancer	0.000393	0.00155	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—breast cancer	0.000392	0.00155	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—breast cancer	0.000392	0.00155	CcSEcCtD
Vecuronium—Tachycardia—Mitoxantrone—breast cancer	0.00039	0.00154	CcSEcCtD
Vecuronium—Anaphylactic shock—Gemcitabine—breast cancer	0.000389	0.00154	CcSEcCtD
Vecuronium—Skin disorder—Mitoxantrone—breast cancer	0.000388	0.00153	CcSEcCtD
Vecuronium—Urticaria—Vinorelbine—breast cancer	0.000385	0.00152	CcSEcCtD
Vecuronium—Anaphylactic shock—Fluorouracil—breast cancer	0.000383	0.00151	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—breast cancer	0.000382	0.00151	CcSEcCtD
Vecuronium—Nervous system disorder—Gemcitabine—breast cancer	0.000382	0.00151	CcSEcCtD
Vecuronium—Skin disorder—Gemcitabine—breast cancer	0.000378	0.00149	CcSEcCtD
Vecuronium—Nervous system disorder—Fluorouracil—breast cancer	0.000376	0.00148	CcSEcCtD
Vecuronium—Tachycardia—Fluorouracil—breast cancer	0.000374	0.00147	CcSEcCtD
Vecuronium—Hypotension—Irinotecan—breast cancer	0.000374	0.00147	CcSEcCtD
Vecuronium—Hypotension—Mitoxantrone—breast cancer	0.000374	0.00147	CcSEcCtD
Vecuronium—Connective tissue disorder—Capecitabine—breast cancer	0.00037	0.00146	CcSEcCtD
Vecuronium—Urticaria—Thiotepa—breast cancer	0.000368	0.00145	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—breast cancer	0.000366	0.00144	CcSEcCtD
Vecuronium—Angioedema—Paclitaxel—breast cancer	0.000365	0.00144	CcSEcCtD
Vecuronium—Hypotension—Gemcitabine—breast cancer	0.000364	0.00144	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000363	0.00143	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—breast cancer	0.000361	0.00142	CcSEcCtD
Vecuronium—Flushing—Docetaxel—breast cancer	0.000361	0.00142	CcSEcCtD
Vecuronium—Hypotension—Fluorouracil—breast cancer	0.000358	0.00141	CcSEcCtD
Vecuronium—Rash—Tamoxifen—breast cancer	0.000357	0.00141	CcSEcCtD
Vecuronium—Hypersensitivity—Vinorelbine—breast cancer	0.000357	0.00141	CcSEcCtD
Vecuronium—Dermatitis—Tamoxifen—breast cancer	0.000357	0.00141	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—breast cancer	0.000353	0.00139	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—breast cancer	0.000351	0.00139	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—breast cancer	0.000351	0.00138	CcSEcCtD
Vecuronium—Rash—Melphalan—breast cancer	0.00035	0.00138	CcSEcCtD
Vecuronium—Flushing—Capecitabine—breast cancer	0.00035	0.00138	CcSEcCtD
Vecuronium—Cardiac disorder—Capecitabine—breast cancer	0.00035	0.00138	CcSEcCtD
Vecuronium—Dermatitis—Melphalan—breast cancer	0.00035	0.00138	CcSEcCtD
Vecuronium—Angiopathy—Capecitabine—breast cancer	0.000342	0.00135	CcSEcCtD
Vecuronium—Rash—Goserelin—breast cancer	0.000341	0.00135	CcSEcCtD
Vecuronium—Hypersensitivity—Thiotepa—breast cancer	0.000341	0.00135	CcSEcCtD
Vecuronium—Dermatitis—Goserelin—breast cancer	0.000341	0.00135	CcSEcCtD
Vecuronium—Immune system disorder—Capecitabine—breast cancer	0.00034	0.00134	CcSEcCtD
Vecuronium—Mediastinal disorder—Capecitabine—breast cancer	0.000339	0.00134	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—breast cancer	0.000339	0.00134	CcSEcCtD
Vecuronium—Erythema—Docetaxel—breast cancer	0.000339	0.00134	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000338	0.00133	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—breast cancer	0.000335	0.00132	CcSEcCtD
Vecuronium—Erythema—Capecitabine—breast cancer	0.000328	0.00129	CcSEcCtD
Vecuronium—Anaphylactic shock—Paclitaxel—breast cancer	0.000326	0.00129	CcSEcCtD
Vecuronium—Shock—Paclitaxel—breast cancer	0.000321	0.00127	CcSEcCtD
Vecuronium—Nervous system disorder—Paclitaxel—breast cancer	0.00032	0.00126	CcSEcCtD
Vecuronium—Tachycardia—Paclitaxel—breast cancer	0.000318	0.00126	CcSEcCtD
Vecuronium—Urticaria—Mitoxantrone—breast cancer	0.000318	0.00125	CcSEcCtD
Vecuronium—Skin disorder—Paclitaxel—breast cancer	0.000317	0.00125	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—breast cancer	0.00031	0.00122	CcSEcCtD
Vecuronium—Rash—Vinorelbine—breast cancer	0.000306	0.00121	CcSEcCtD
Vecuronium—Dermatitis—Vinorelbine—breast cancer	0.000305	0.0012	CcSEcCtD
Vecuronium—Hypotension—Paclitaxel—breast cancer	0.000305	0.0012	CcSEcCtD
Vecuronium—Urticaria—Fluorouracil—breast cancer	0.000304	0.0012	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—breast cancer	0.000295	0.00116	CcSEcCtD
Vecuronium—Hypersensitivity—Mitoxantrone—breast cancer	0.000295	0.00116	CcSEcCtD
Vecuronium—Rash—Thiotepa—breast cancer	0.000292	0.00115	CcSEcCtD
Vecuronium—Dermatitis—Thiotepa—breast cancer	0.000292	0.00115	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000286	0.00113	CcSEcCtD
Vecuronium—Hypersensitivity—Fluorouracil—breast cancer	0.000282	0.00111	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000277	0.00109	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—breast cancer	0.000276	0.00109	CcSEcCtD
Vecuronium—Shock—Docetaxel—breast cancer	0.000272	0.00107	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—breast cancer	0.000271	0.00107	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—breast cancer	0.00027	0.00106	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—breast cancer	0.000268	0.00106	CcSEcCtD
Vecuronium—Shock—Capecitabine—breast cancer	0.000263	0.00104	CcSEcCtD
Vecuronium—Nervous system disorder—Capecitabine—breast cancer	0.000262	0.00104	CcSEcCtD
Vecuronium—Tachycardia—Capecitabine—breast cancer	0.000261	0.00103	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—breast cancer	0.00026	0.00103	CcSEcCtD
Vecuronium—Skin disorder—Capecitabine—breast cancer	0.00026	0.00103	CcSEcCtD
Vecuronium—Urticaria—Paclitaxel—breast cancer	0.000259	0.00102	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—breast cancer	0.000258	0.00102	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—breast cancer	0.000258	0.00102	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—breast cancer	0.000254	0.001	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—breast cancer	0.000253	0.000999	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—breast cancer	0.000253	0.000997	CcSEcCtD
Vecuronium—Rash—Irinotecan—breast cancer	0.000252	0.000994	CcSEcCtD
Vecuronium—Rash—Mitoxantrone—breast cancer	0.000252	0.000994	CcSEcCtD
Vecuronium—Dermatitis—Mitoxantrone—breast cancer	0.000252	0.000993	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—breast cancer	0.000252	0.000993	CcSEcCtD
Vecuronium—Hypotension—Capecitabine—breast cancer	0.00025	0.000986	CcSEcCtD
Vecuronium—Rash—Gemcitabine—breast cancer	0.000246	0.000969	CcSEcCtD
Vecuronium—Dermatitis—Gemcitabine—breast cancer	0.000245	0.000968	CcSEcCtD
Vecuronium—Erythema—Methotrexate—breast cancer	0.000244	0.000963	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—breast cancer	0.000244	0.000961	CcSEcCtD
Vecuronium—Flushing—Epirubicin—breast cancer	0.000244	0.000961	CcSEcCtD
Vecuronium—Rash—Fluorouracil—breast cancer	0.000241	0.000952	CcSEcCtD
Vecuronium—Dermatitis—Fluorouracil—breast cancer	0.000241	0.000952	CcSEcCtD
Vecuronium—Hypersensitivity—Paclitaxel—breast cancer	0.00024	0.000948	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—breast cancer	0.000239	0.000941	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—breast cancer	0.000238	0.000939	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—breast cancer	0.000237	0.000935	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—breast cancer	0.000236	0.000933	CcSEcCtD
Vecuronium—Erythema—Epirubicin—breast cancer	0.000228	0.000901	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—breast cancer	0.000225	0.000889	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—breast cancer	0.000225	0.000889	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—breast cancer	0.00022	0.000869	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—breast cancer	0.000219	0.000865	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—breast cancer	0.000219	0.000863	CcSEcCtD
Vecuronium—Urticaria—Capecitabine—breast cancer	0.000213	0.000839	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—breast cancer	0.000211	0.000834	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000206	0.000814	CcSEcCtD
Vecuronium—Rash—Paclitaxel—breast cancer	0.000206	0.000811	CcSEcCtD
Vecuronium—Dermatitis—Paclitaxel—breast cancer	0.000205	0.00081	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—breast cancer	0.000204	0.000803	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—breast cancer	0.000199	0.000786	CcSEcCtD
Vecuronium—Hypersensitivity—Capecitabine—breast cancer	0.000197	0.000778	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—breast cancer	0.000195	0.000771	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—breast cancer	0.000193	0.000763	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000193	0.000762	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—breast cancer	0.000186	0.000735	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—breast cancer	0.000186	0.000734	CcSEcCtD
Vecuronium—Shock—Epirubicin—breast cancer	0.000183	0.000723	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—breast cancer	0.000183	0.000721	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—breast cancer	0.000182	0.000718	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—breast cancer	0.000181	0.000714	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000179	0.000705	CcSEcCtD
Vecuronium—Rash—Docetaxel—breast cancer	0.000174	0.000687	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—breast cancer	0.000174	0.000687	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—breast cancer	0.000174	0.000687	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—breast cancer	0.000172	0.00068	CcSEcCtD
Vecuronium—Shock—Doxorubicin—breast cancer	0.00017	0.000669	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—breast cancer	0.000169	0.000667	CcSEcCtD
Vecuronium—Rash—Capecitabine—breast cancer	0.000169	0.000666	CcSEcCtD
Vecuronium—Dermatitis—Capecitabine—breast cancer	0.000169	0.000665	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—breast cancer	0.000168	0.000664	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—breast cancer	0.000168	0.000661	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—breast cancer	0.000161	0.000636	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—breast cancer	0.000158	0.000624	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—breast cancer	0.000148	0.000584	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—breast cancer	0.000147	0.000579	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—breast cancer	0.000137	0.000542	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—breast cancer	0.000137	0.000541	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—breast cancer	0.000127	0.000501	CcSEcCtD
Vecuronium—Rash—Methotrexate—breast cancer	0.000126	0.000495	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—breast cancer	0.000125	0.000495	CcSEcCtD
Vecuronium—Rash—Epirubicin—breast cancer	0.000118	0.000464	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—breast cancer	0.000117	0.000463	CcSEcCtD
Vecuronium—Rash—Doxorubicin—breast cancer	0.000109	0.000429	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—breast cancer	0.000109	0.000429	CcSEcCtD
Vecuronium—ABCB1—Allograft Rejection—CASP3—breast cancer	4.11e-05	0.00074	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2—breast cancer	4.11e-05	0.000739	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	4.05e-05	0.000728	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	4.03e-05	0.000725	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A5—breast cancer	4e-05	0.00072	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLCO1B1—breast cancer	4e-05	0.00072	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	4e-05	0.000719	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	4e-05	0.000719	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	3.94e-05	0.000709	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	3.92e-05	0.000706	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	3.88e-05	0.000698	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APRT—breast cancer	3.87e-05	0.000695	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TFRC—breast cancer	3.87e-05	0.000695	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	3.84e-05	0.00069	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	3.78e-05	0.00068	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	3.75e-05	0.000675	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—breast cancer	3.73e-05	0.000671	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NCOA2—breast cancer	3.72e-05	0.000669	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—RAF1—breast cancer	3.72e-05	0.000668	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	3.67e-05	0.00066	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ANGPTL4—breast cancer	3.64e-05	0.000654	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ESRRA—breast cancer	3.64e-05	0.000654	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—HRAS—breast cancer	3.59e-05	0.000646	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.55e-05	0.000638	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—breast cancer	3.49e-05	0.000628	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPI—breast cancer	3.45e-05	0.00062	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HADHB—breast cancer	3.45e-05	0.00062	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.43e-05	0.000617	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HRAS—breast cancer	3.41e-05	0.000614	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—BRAF—breast cancer	3.41e-05	0.000613	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—breast cancer	3.33e-05	0.000599	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	3.32e-05	0.000597	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALDH1A1—breast cancer	3.29e-05	0.000591	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALDH7A1—breast cancer	3.29e-05	0.000591	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	3.24e-05	0.000582	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SYNJ2—breast cancer	3.22e-05	0.000578	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TGFB1—breast cancer	3.2e-05	0.000576	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NME1—breast cancer	3.15e-05	0.000567	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—FHL2—breast cancer	3.15e-05	0.000567	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UMPS—breast cancer	3.15e-05	0.000567	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ADSL—breast cancer	3.15e-05	0.000567	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PHGDH—breast cancer	3.15e-05	0.000567	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NCOA1—breast cancer	3.14e-05	0.000564	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	3.12e-05	0.000561	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPSE—breast cancer	3.09e-05	0.000556	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—BRIP1—breast cancer	3.09e-05	0.000556	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LDHB—breast cancer	3.09e-05	0.000556	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	3.07e-05	0.000553	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	3.06e-05	0.00055	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—PLG—breast cancer	3.06e-05	0.00055	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	3.05e-05	0.000548	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TNF—breast cancer	2.99e-05	0.000538	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NDUFS3—breast cancer	2.99e-05	0.000538	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	2.97e-05	0.000535	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA3—breast cancer	2.93e-05	0.000527	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMMR—breast cancer	2.93e-05	0.000527	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCC1—breast cancer	2.93e-05	0.000527	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.88e-05	0.000518	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MDM2—breast cancer	2.86e-05	0.000514	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—RAF1—breast cancer	2.85e-05	0.000512	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.85e-05	0.000512	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARGC1B—breast cancer	2.84e-05	0.00051	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—breast cancer	2.82e-05	0.000507	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CHST9—breast cancer	2.81e-05	0.000506	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	2.71e-05	0.000487	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.68e-05	0.000482	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CA9—breast cancer	2.68e-05	0.000482	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA4—breast cancer	2.68e-05	0.000482	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COX11—breast cancer	2.67e-05	0.000479	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.64e-05	0.000474	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA2—breast cancer	2.61e-05	0.00047	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPX2—breast cancer	2.61e-05	0.00047	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.59e-05	0.000467	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPX4—breast cancer	2.58e-05	0.000464	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SULT1A1—breast cancer	2.58e-05	0.000464	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	2.57e-05	0.000462	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	2.54e-05	0.000457	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA1—breast cancer	2.52e-05	0.000453	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—IDH1—breast cancer	2.52e-05	0.000453	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NAT2—breast cancer	2.49e-05	0.000448	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SHMT1—breast cancer	2.44e-05	0.000438	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CDA—breast cancer	2.44e-05	0.000438	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLCO1B1—breast cancer	2.35e-05	0.000422	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A5—breast cancer	2.35e-05	0.000422	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.3e-05	0.000414	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.27e-05	0.000408	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APRT—breast cancer	2.27e-05	0.000408	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	2.27e-05	0.000407	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.26e-05	0.000406	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.24e-05	0.000402	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.19e-05	0.000393	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MED12—breast cancer	2.18e-05	0.000393	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—DPYD—breast cancer	2.18e-05	0.000393	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.18e-05	0.000392	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALDOA—breast cancer	2.15e-05	0.000387	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ESRRA—breast cancer	2.13e-05	0.000383	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ANGPTL4—breast cancer	2.13e-05	0.000383	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA3—breast cancer	2.09e-05	0.000376	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.08e-05	0.000374	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A2—breast cancer	2.07e-05	0.000373	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.07e-05	0.000372	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	2.05e-05	0.000368	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCG2—breast cancer	2.03e-05	0.000365	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CPT1A—breast cancer	2.03e-05	0.000365	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTR—breast cancer	2.03e-05	0.000365	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	2.03e-05	0.000365	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPI—breast cancer	2.02e-05	0.000363	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HADHB—breast cancer	2.02e-05	0.000363	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.01e-05	0.000361	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPGDS—breast cancer	1.99e-05	0.000358	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HBA1—breast cancer	1.98e-05	0.000356	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.98e-05	0.000355	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.97e-05	0.000355	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.96e-05	0.000352	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTT1—breast cancer	1.93e-05	0.000347	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACHE—breast cancer	1.93e-05	0.000347	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALDH7A1—breast cancer	1.93e-05	0.000347	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALDH1A1—breast cancer	1.93e-05	0.000347	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.91e-05	0.000344	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.91e-05	0.000343	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.87e-05	0.000335	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PHGDH—breast cancer	1.85e-05	0.000332	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADSL—breast cancer	1.85e-05	0.000332	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NME1—breast cancer	1.85e-05	0.000332	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UMPS—breast cancer	1.85e-05	0.000332	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FHL2—breast cancer	1.85e-05	0.000332	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.84e-05	0.00033	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP17A1—breast cancer	1.83e-05	0.000329	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LDHB—breast cancer	1.81e-05	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—BRIP1—breast cancer	1.81e-05	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPSE—breast cancer	1.81e-05	0.000326	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS1—breast cancer	1.81e-05	0.000326	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ENO1—breast cancer	1.81e-05	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.79e-05	0.000322	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2D6—breast cancer	1.78e-05	0.000319	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.77e-05	0.000318	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA2—breast cancer	1.74e-05	0.000313	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.72e-05	0.00031	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCC1—breast cancer	1.72e-05	0.000309	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMMR—breast cancer	1.72e-05	0.000309	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA3—breast cancer	1.72e-05	0.000309	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	1.69e-05	0.000304	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—FASN—breast cancer	1.69e-05	0.000304	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—BCHE—breast cancer	1.68e-05	0.000303	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARGC1B—breast cancer	1.66e-05	0.000299	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC5A5—breast cancer	1.66e-05	0.000299	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.65e-05	0.000297	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.63e-05	0.000293	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NQO1—breast cancer	1.61e-05	0.000289	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A1—breast cancer	1.61e-05	0.000289	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.58e-05	0.000285	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.58e-05	0.000284	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA4—breast cancer	1.57e-05	0.000283	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CA9—breast cancer	1.57e-05	0.000283	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HRAS—breast cancer	1.57e-05	0.000282	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP3A4—breast cancer	1.57e-05	0.000282	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.55e-05	0.000279	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1B1—breast cancer	1.54e-05	0.000277	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	1.53e-05	0.000275	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA2—breast cancer	1.53e-05	0.000275	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPX2—breast cancer	1.53e-05	0.000275	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPX4—breast cancer	1.51e-05	0.000272	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SULT1A1—breast cancer	1.51e-05	0.000272	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSP90AA1—breast cancer	1.51e-05	0.000271	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—IDH1—breast cancer	1.48e-05	0.000266	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA1—breast cancer	1.48e-05	0.000266	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.48e-05	0.000265	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA1—breast cancer	1.47e-05	0.000264	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.46e-05	0.000263	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NAT2—breast cancer	1.46e-05	0.000263	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP19A1—breast cancer	1.45e-05	0.00026	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—STK11—breast cancer	1.45e-05	0.00026	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—COMT—breast cancer	1.35e-05	0.000242	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.35e-05	0.000242	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTP1—breast cancer	1.34e-05	0.000241	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMOX1—breast cancer	1.32e-05	0.000238	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ITPR1—breast cancer	1.32e-05	0.000237	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.3e-05	0.000234	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MED12—breast cancer	1.28e-05	0.00023	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—DPYD—breast cancer	1.28e-05	0.00023	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCB1—breast cancer	1.27e-05	0.000228	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALDOA—breast cancer	1.26e-05	0.000227	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TYMS—breast cancer	1.24e-05	0.000224	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOR1—breast cancer	1.23e-05	0.000221	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLA2G4A—breast cancer	1.23e-05	0.000221	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—breast cancer	1.23e-05	0.000221	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA3—breast cancer	1.22e-05	0.00022	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A2—breast cancer	1.22e-05	0.000219	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTR—breast cancer	1.19e-05	0.000214	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CPT1A—breast cancer	1.19e-05	0.000214	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCG2—breast cancer	1.19e-05	0.000214	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPX1—breast cancer	1.18e-05	0.000212	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPGDS—breast cancer	1.17e-05	0.00021	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1A1—breast cancer	1.17e-05	0.00021	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HBA1—breast cancer	1.16e-05	0.000209	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ERCC2—breast cancer	1.16e-05	0.000208	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTT1—breast cancer	1.13e-05	0.000204	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACHE—breast cancer	1.13e-05	0.000204	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.1e-05	0.000198	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTHFR—breast cancer	1.09e-05	0.000196	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP17A1—breast cancer	1.07e-05	0.000193	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ENO1—breast cancer	1.06e-05	0.000191	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS1—breast cancer	1.06e-05	0.000191	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2D6—breast cancer	1.04e-05	0.000187	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA2—breast cancer	1.02e-05	0.000184	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CAV1—breast cancer	1e-05	0.00018	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	9.92e-06	0.000178	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FASN—breast cancer	9.91e-06	0.000178	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—BCHE—breast cancer	9.86e-06	0.000177	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC5A5—breast cancer	9.74e-06	0.000175	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A1—breast cancer	9.41e-06	0.000169	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NQO1—breast cancer	9.41e-06	0.000169	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP3A4—breast cancer	9.18e-06	0.000165	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CG—breast cancer	9.14e-06	0.000164	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1B1—breast cancer	9.02e-06	0.000162	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.97e-06	0.000161	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSP90AA1—breast cancer	8.85e-06	0.000159	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA1—breast cancer	8.61e-06	0.000155	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—STK11—breast cancer	8.48e-06	0.000153	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP19A1—breast cancer	8.48e-06	0.000153	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CD—breast cancer	8.03e-06	0.000144	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALB—breast cancer	7.93e-06	0.000143	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COMT—breast cancer	7.89e-06	0.000142	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTP1—breast cancer	7.85e-06	0.000141	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMOX1—breast cancer	7.74e-06	0.000139	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ITPR1—breast cancer	7.72e-06	0.000139	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NOS3—breast cancer	7.59e-06	0.000136	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TYMS—breast cancer	7.3e-06	0.000131	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLA2G4A—breast cancer	7.21e-06	0.00013	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOR1—breast cancer	7.21e-06	0.00013	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—breast cancer	7.21e-06	0.00013	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CB—breast cancer	7e-06	0.000126	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS2—breast cancer	6.94e-06	0.000125	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPX1—breast cancer	6.91e-06	0.000124	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1A1—breast cancer	6.84e-06	0.000123	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ERCC2—breast cancer	6.78e-06	0.000122	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTHFR—breast cancer	6.37e-06	0.000115	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTEN—breast cancer	6.05e-06	0.000109	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CAV1—breast cancer	5.88e-06	0.000106	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CG—breast cancer	5.36e-06	9.63e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CD—breast cancer	4.71e-06	8.47e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALB—breast cancer	4.65e-06	8.36e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NOS3—breast cancer	4.45e-06	8e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CA—breast cancer	4.27e-06	7.68e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CB—breast cancer	4.1e-06	7.38e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS2—breast cancer	4.07e-06	7.31e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTEN—breast cancer	3.55e-06	6.38e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—breast cancer	3.49e-06	6.27e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CA—breast cancer	2.5e-06	4.5e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—breast cancer	2.04e-06	3.68e-05	CbGpPWpGaD
